These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16612645)

  • 41. Wanted: guidelines for "palliative" anti-cancer drug use.
    Kearsley JH
    Med J Aust; 1994 Jun; 160(11):723-5. PubMed ID: 7515460
    [No Abstract]   [Full Text] [Related]  

  • 42. A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features.
    Javadpour N; Ozols RF; Anderson T; Barlock AB; Wesley R; Young RC
    Cancer; 1982 Nov; 50(10):2004-10. PubMed ID: 6751514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advanced testicular cancer: update for urologists.
    Einhorn LH; Donohue JP
    J Urol; 1998 Dec; 160(6 Pt 1):1964-9. PubMed ID: 9817300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study activities for testicular cancer].
    Krege S
    Urologe A; 2005 Dec; 44(12):1439-43. PubMed ID: 16283154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy for advanced or recurrent cervical cancer.
    Kamura T; Ushijima K
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):161-4. PubMed ID: 23915846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.
    Kollmannsberger C; Daneshmand S; So A; Chi KN; Murray N; Moore C; Hayes-Lattin B; Nichols C
    J Clin Oncol; 2010 Feb; 28(4):537-42. PubMed ID: 20026807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy.
    Labbate CV; Werntz RP; Galansky LB; Packiam VT; Eggener SE
    Urol Oncol; 2020 Aug; 38(8):687.e13-687.e18. PubMed ID: 32305267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evidence based medicine indications for radiation therapy in testicular germ cell tumours].
    Souchon R; Classen J; Schmidberger H
    Urologe A; 2004 Dec; 43(12):1500-6. PubMed ID: 15502911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer.
    Hartmann JT; Kuczyk MA; Kollmannsberger C; Kanz L; Bokemeyer C
    World J Urol; 1999 Oct; 17(5):324-33. PubMed ID: 10552153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
    Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal number of chemotherapy courses in advanced nonseminomatous testicular carcinoma.
    Kennedy BJ; Torkelson J; Fraley EE
    Am J Clin Oncol; 1995 Dec; 18(6):463-8. PubMed ID: 8526185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New guidelines for clinical stage I testicular seminoma?
    Christoph F; Weikert S; Miller K; Schrader M
    Oncology; 2005; 69(6):455-62. PubMed ID: 16374039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combined surgical and cytostatic therapy in patients with advanced metastatic nonseminomatous testicular cancer (author's transl)].
    Brehmer B; Hossfeld DK; Kersting D
    Urologe A; 1977 Nov; 16(6):331-3. PubMed ID: 74890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
    Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
    J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Paraneoplastic syndrome in renal cell carcinoma].
    Bedke J; Buse S; Kurosch M; Haferkamp A; Jäger D; Hohenfellner M
    Urologe A; 2007 Jan; 46(1):45-8. PubMed ID: 17186189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.
    Ozols RF; Deisseroth AB; Javadpour N; Barlock A; Messerschmidt GL; Young RC
    Cancer; 1983 May; 51(10):1803-7. PubMed ID: 6187426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comprehensive management of residual tumor in patients with an advanced testicular tumor].
    Inamoto T; Azuma H
    Hinyokika Kiyo; 2012 Dec; 58(12):737-42. PubMed ID: 23328176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
    Kollmannsberger C; Mayer F; Kuczyk M; Kanz L; Bokemeyer C
    World J Urol; 2001 Apr; 19(2):120-5. PubMed ID: 11374314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.